Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019

SELL
$76.06 - $120.81 $24,339 - $38,659
-320 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$113.81 - $129.46 $3,414 - $3,883
30 Added 10.34%
320 $41,000
Q4 2017

Feb 13, 2018

SELL
$118.58 - $151.28 $2,964 - $3,782
-25 Reduced 7.94%
290 $43,000
Q3 2017

Nov 13, 2017

BUY
$114.6 - $136.81 $36,099 - $43,095
315
315 $37,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.5B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Israel Discount Bank Of New York Portfolio

Follow Israel Discount Bank Of New York and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Israel Discount Bank Of New York, based on Form 13F filings with the SEC.

News

Stay updated on Israel Discount Bank Of New York with notifications on news.